GlaxoSmithKline and Ener-G feted in energy awards 02 January 2013

GlaxoSmithKline and combined heat and power (CHP) specialist Ener-G have been highly commended by the Combined Heat and Power Association (CHPA) for their installation of more than 20MW of CHP across eight GSK sites in the UK and Europe.

The project is achieving an annual CO2 reduction of 15% – equating to more than 62,915 tonnes – as well as financial savings through operating more efficient power generation systems.

The first CHP plant, at GSK's Worthing site in West Sussex, became operational in June 2009, while the most recent site, at Ware GMS, in Hertfordshire, went live in September 2011. All are almost twice as efficient as conventional power generation as the majority of heat is recovered and used on site.

The overall project involved installation of six Ener-G 2MWe cogeneration units, five Ener-G 1,150kWe units, one Ener-G 1600kWe unit and two Ener-G 1MWe units, all natural gas-fired and all providing electricity, hot water and steam to the production facilities.

Now in their fifth year, the CHPA Awards showcase achievement, innovation and best practice from across the sector.

"These awards demonstrate that green is working, with investment in energy efficiency making real business sense as we pull out of recession," comments CHPA director Graham Meeks.

"It is very positive to see the extent to which the industry has responded to the present economic difficulties, making investment in CHP systems increasingly affordable and making their operation increasingly flexible."

Brian Tinham

Related Companies
ENER-G plc
GlaxoSmithKline plc

This material is protected by MA Business copyright
See Terms and Conditions.
One-off usage is permitted but bulk copying is not.
For multiple copies contact the sales team.